Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20

NCT03605238 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped It was hard to recruit patients

Conditions

Neuromyelitis Optica Spectrum Disorder

Interventions

BIOLOGICAL: Corticosteroids & tanCART19/20

Sponsor

Chinese PLA General Hospital